{
  "name": "89bio",
  "description": "A biotechnology firm is advancing a Phase 3 trial for a metabolic liver disease treatment and has made stock-based inducement grants under Nasdaq guidelines.",
  "categoryId": 12,
  "size": "m",
  "logoFile": "logos/89_bio-logo.webp",
  "websiteUrl": "https://www.89bio.com/",
  "careersUrl": "https://www.89bio.com/careers/",
  "linkedinId": "89bio",
  "linkedinNum": 54350802,
  "crunchbaseId": null,
  "ivcId": null,
  "finderId": "89bio",
  "xId": null,
  "facebookId": null,
  "breezyId": null,
  "comeetId": null,
  "greenhouseId": null,
  "leverId": null,
  "addresses": [
    {
      "street": "אופנהיימר",
      "houseNumber": 4,
      "city": "רחובות",
      "lat": 31.9104321,
      "lon": 34.8058374
    }
  ],
  "isMultinational": false,
  "isActive": true
}